Press release
Why are the chest implants most common venous procedure device application area?
Big data and analytics will drive patient outcomes in a big way, and the coming years will witness a growing emphasis on healthcare service providers in the business of gathering and processing patient health data.Click HERE to Get Complete Synopsis of the Report- https://www.factmr.com/report/venous-procedure-devices-market
Award-winning consulting firm Fact.MR recently published a report on the global venous procedure devices market, for the forecast period 2021-2031. According to the study, the market is projected to surpass US$ 3 billion in value by the end of the aforementioned forecast period (2021 to 2031), expanding at a CAGR of around 6%. Growth is majorly influenced by an increase in vascular disease procedures.
Historically, the market posted credible gains, being valued at around US$ 2 billion in 2019. A host of established as well as incumbent market players are scrambling to secure a firm footing in the landscape. AIincreasing number of startups are capitalizing on incremental opportunities presented by key segments across the venous procedure devices market.
To remain ‘ahead’ of your competitors, request for a sample – https://www.factmr.com/connectus/sample?flag=S&rep_id=6087
Inari Medical, for instance, offers the Flow Triever catheter-based thrombectomy device shown to extract significant amounts of clot from large blood vessels. It has a self-expanding Nitinol framework designed to engage, disrupt and remove emboli from blood vessels with minimal trauma. Likewise, Silk Road Medical produces devices for Transcarotid artery revascularization (TAR) procedure for carotid artery disease. Its products include the EnRoute Transcarotid Neuroprotection and the EnRoute Stent system.
“Purpose-built venous stents offer promising growth prospects, attributed to their ability to achieve efficient arterial pulsation and mobility for treating occlusion diseases. Hence, prominent manufacturers are collaborating with medical technology consulting firms to deepen their outreach,” comments a Fact.MR analyst.
Need more information about Report Methodology? Click here- https://www.factmr.com/connectus/sample?flag=RM&rep_id=6087
Market Segmentation
By Product
Venous Stents
Drug Eluting Venous Stents
Non-drug Eluting Venous Stents
Catheters
Central Venous Catheters
Subcutaneous (Implanted) Ports
Peripherally Inserted Central Catheters (PICC)
Guidewires
Standard
High Support
Flexible
Chronic Total Occlusion
Others
By Application
Leg
Chest
Abdomen
Arm
Get Customisation of this Report: https://www.factmr.com/connectus/sample?flag=RC&rep_id=6087
By Indication
Vascular Diseases
Chronic Deep Vein Thrombosis
Post-thrombotic Syndrome
May-Thurner Syndrome
Hemodialysis/Arteriovenous Fistulae
Others
Cancer
By End User
Hospitals
Ambulatory Surgical Centers
Specialty Clinics
Others
By Region
North America
Europe
Asia-Pacific
Latin America
Middle East & Africa
Key Takeaways from Market Study
By product, central venous catheters to experience sharp incline amid greater effectiveness
By application, chest venous procedure devices to remain dominant, abdomen devices uptake expanding rapidly
Venous procedure devices for vascular diseases will experience robust incline through 2031
By end user, hospitals to remain primary source of venous procedure devices implanting
The U.S. to emerge as a potential growth hotspot amid increased prevalence of peripheral arterial disease
India to cement its dominance across the South Asian market
For comprehensive insights on this market adoption, ask an analyst here- https://www.factmr.com/connectus/sample?flag=AE&rep_id=6087
Competitive Landscape
Medtronic Plc., Abbott Laboratories, Cook Medical, Cardinal Health, Becton Dickinson & Co. (BD), Terumo Corporation, Boston Scientific Corporation and Teleflex are some prominent venous procedure devices manufacturers. Most players rely on introducing new devices post regulatory approvals across key geographies, in addition to other expansion strategies such as collaborations, mergers & acquisitions and partnerships respectively.
For instance, in May 2019, Cordis, a Cardinal Health company, announced the full US launch of its RADIAL 360 portfolio, offering a complete range of products to facilitate the tranradial approach (TRA) for interventional cardiology. The portfolio consists of RAIN SheathTM Transradial Thin-Walled Introducer, RAILWAYTM Sheathless Access System and the ZEPHYR® Vascular Compression Brand among others
In April 2021, Becton Dickinson (BD) announced enrollment in its post-market studies of the WavelinQTM Arteriovenous Endovascular Fistula device which uses concomitant ulnar artery and ulnar vein in patients suffering from chronic kidney diseases, expected to enroll 280 participants through 30 days
More Valuable Insights Available
Fact.MR, in its new offering, presents an unbiased analysis of the venous procedure devices market, presenting historical demand data (2016-2020) and forecast statistics for the period of 2021-2031. The study divulges essential insights on the market on the basis of product (stents, catheters, and others), application (leg, chest, abdomen, and arm), indication (vascular diseases and cancer), and end user (hospitals, ambulatory surgical centers, specialty clinics, and others) across five major regions of the world (North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa).
For More Insights: https://www.prnewswire.com/news-releases/blood-collection-tubes-for-liquid-biopsy-sales-set-to-grow-at-12-through-2021-factmr-301245568.html
Major Players operate within the market
Medtronic Plc.
Cardinal Health
Becton Dickinson & Co. (BD)
Terumo Corporation
Teleflex Incorporated
Boston Scientific Corporation
Optimed Medizinische Instrumente GmbH
Cook Medical
B. Braun Melsungen AG
Abbott Laboratories
Full Access of this Exclusive Report is Available at- https://www.factmr.com/checkout/6087/S
US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates
Email : sales@factmr.com
Website : https://www.factmr.com
About Fact.MR
Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions.
We have offices in US and Dublin, whereas our global headquarter is in Dubai.While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise.
Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed.
Reach out to us with your goals, and we’ll be an able research partner.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Why are the chest implants most common venous procedure device application area? here
News-ID: 2289716 • Views: …
More Releases from Fact.MR
Blockchain in Telecom Market to Surge from USD 795.8 Million in 2025 to USD 211, …
The global blockchain in telecom market is making significant strides as telecom operators, infrastructure providers, and technology vendors increasingly turn to decentralized ledger technologies to address challenges such as fraud, identity verification, and transparency. According to the latest Fact.MR analysis, the market is valued at USD 795.8 million in 2025, illustrating how blockchain is no longer a fringe concept but a growing core component in telecom strategies.
Telecom companies are…
Translation Software Market Growing at around 6.5% CAGR (2025-2035)
The translation software market has reached an estimated value of USD 10.7 billion in 2025, as globalization intensifies and digital content proliferates across industries. Businesses are increasingly publishing content in multiple languages to capture international markets, comply with regulations, and improve customer experience. Advances in artificial intelligence, especially neural machine translation models, are enhancing accuracy and reducing time lag, making software translation a more viable alternative to human translation for…
Sterility Indicators Market Valued at USD 1.37 Billion in 2025 | Fact.MR Analysi …
The global sterility indicators market has firmly established its importance by 2025, reaching an estimated valuation of USD 1.37 billion. This growth reflects increasing global emphasis on infection prevention, sterilization validation, and quality compliance in healthcare, pharmaceutical, and medical device manufacturing sectors. Hospitals, clinics, and labs are demanding both biological and chemical indicators to ensure that sterilization processes-whether via steam, heat, radiation, or chemical agents-meet the required safety and regulatory…
Antibody Fragments Market is Growing at a CAGR of 6.2% by 2035 | Key Players: No …
The global antibody fragments market has firmly established its importance in biopharmaceuticals and diagnostics by 2024, achieving a valuation of approximately USD 8,563 million. Growth to this level has been driven by increasing incidence of chronic and immunological disorders, rising demand for more precise and targeted therapies, and improvements in biologic technologies.
Antibody fragments, which include Fab, scFv, sdAb and other smaller binding modules, are finding favor due to their…
More Releases for Venous
States Venous Stents Market Projected to Witness Expansion with Rising Incidence …
States Venous Stents Market Overview
The States Venous Stents Market is expected to grow from USD 1.3 billion in 2025 to USD 2.4 billion by 2032, registering a CAGR of 8.9%.
Coherent Market Insights is pleased to release its latest States Venous Stents Market research report, offering an in-depth analysis of the U.S. States Venous Stents Market Landscape from 2025 to 2032. This report delivers reliable projections across national and regional levels,…
Venous Stent Market Grows with Rising Cases of Chronic Venous Disorders | Boston …
Venous Stent Market Overview
The venous stent market is anticipated to grow from USD 0.6 billion in 2025 to USD 1.3 billion by 2032, exhibiting a CAGR of 10.3% during the forecast period.
Coherent Market Insights is proud to announce the release of its latest market research report, providing a comprehensive analysis of the Venous Stent Market Landscape from 2025 to 2032. This report delivers precise forecasts across global, regional, and country…
Major Force in the Venous Thromboembolism Market 2025: Impact Of Healthcare Infr …
How Will the Venous Thromboembolism Market Grow, and What Is the Projected Market Size?
Over the past few years, the venous thromboembolism market has experienced a steady increase in its size. It's projected to expand from $2.44 billion in 2024 to $2.55 billion in 2025, rising at a compound annual growth rate (CAGR) of 4.4%. The growth during the historic period can be credited to an increasing elderly population, progress in…
Venous Catheter Market Size 2024 to 2031.
Market Overview and Report Coverage
A venous catheter is a small, flexible tube inserted into a vein for medical purposes such as accessing the bloodstream for medications, fluids, or blood sampling. The venous catheter market is expected to witness significant growth in the coming years, with a projected CAGR of 6.30% during the forecasted period.
The current outlook for the venous catheter market is positive, driven by factors such as…
Venous Skin Ulcer Treatment Market : Lucrative Opportunities
Venous Skin Ulcer Treatment Market: Introduction
According to the report, the global venous skin ulcer treatment market was valued at US$ 2.6 Bn in 2019. It is expected to expand at a CAGR of ~5% during the forecast period from 2020 to 2030. Various advanced technologies and treatment options are presently available for venous skin ulcer. The treatment for skin ulcer include different therapies such as compression therapy, advanced wound dressings,…
Increasing Prevalence of Venous Thromboembolism to Augment Growth of the Venous …
Venous thromboembolism (VTE) is the formation of blood clots in the bloodstream. Two main types of venous thromboembolism are pulmonary embolism and deep vein thrombosis. The formation of blood clots in a deep vein is called deep vein thrombosis, while the deep vein thrombosis formed breaks the clot and travels to the lungs, known as pulmonary embolism.
Sample Copy Of Report @ https://www.coherentmarketinsights.com/insight/request-sample/188
Pulmonary embolism occurs in almost one-third of patients…
